Siv Jonsson

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks.

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks.

Journal: NPJ precision oncology

Published: February 12, 2026

Conditional Versus Unconditional Covariate Effects in Pharmacometric Models: Implications for Interpretation, Communication, and Reporting.

Conditional Versus Unconditional Covariate Effects in Pharmacometric Models: Implications for Interpretation, Communication, and Reporting.

Journal: CPT: pharmacometrics & systems pharmacology

Published: August 21, 2025

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

Journal: EClinicalMedicine

Published: June 05, 2025

A Model-Based Approach to Evaluate Anti-Drug Antibody Impact on Drug Exposure With Biologics: A Case Example With the CD3 T-Cell Bispecific Cibisatamab.

A Model-Based Approach to Evaluate Anti-Drug Antibody Impact on Drug Exposure With Biologics: A Case Example With the CD3 T-Cell Bispecific Cibisatamab.

Journal: CPT: pharmacometrics & systems pharmacology

Published: October 31, 2024

Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort.

Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort.

Journal: The Journal of antimicrobial chemotherapy

Published: October 02, 2024

Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.

Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.

Journal: Clinical pharmacology and therapeutics

Published: September 19, 2024

Combining mathematical modeling, in vitro data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBL.

Combining mathematical modeling, in vitro data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBL.

Journal: Frontiers in pharmacology

Published: July 29, 2024

Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK2 receptors, in infants with colic.

Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK2 receptors, in infants with colic.

Journal: British journal of clinical pharmacology

Published: March 05, 2024

A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno-oncology.

A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno-oncology.

Journal: CPT: pharmacometrics & systems pharmacology

Published: July 10, 2023

Therapeutic drug monitoring of vancomycin and meropenem: Illustration of the impact of inaccurate information in dose administration time.

Therapeutic drug monitoring of vancomycin and meropenem: Illustration of the impact of inaccurate information in dose administration time.

Journal: International journal of antimicrobial agents

Published: May 20, 2023

Characterization of anti-drug antibody dynamics using a bivariate mixed hidden-markov model by nonlinear-mixed effects approach.

Characterization of anti-drug antibody dynamics using a bivariate mixed hidden-markov model by nonlinear-mixed effects approach.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: March 31, 2023

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Journal: CPT: pharmacometrics & systems pharmacology

Published: January 18, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026